Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Methicillin-Resistant Staphylococcus aureus: HELP
James A. McKinnell
Based on 19 articles published since 2009
(Why 19 articles?)
||||
Expertise Level
The expertise of James A. McKinnell ranks in the Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases McKinnell, James A   ·   McKinnell, J   ·   McKinnell, J A   ·   McKinnell, James
Work Locations
Details
Most likely:    UCLA   Contact    
2019
  • From the Division of Infectious Diseases (S.S. Huang, R.S., S.P., D.K., S.R., T.T., C. Cao, S.S. Hong, J.L., E.C., J.C., J.H.), the Health Policy Research Institute (S.S. Huang), and the Department of Medicine (A.A.), University of California Irvine School of Medicine, and the Institute for Clinical and Translational Science (A.G.) and the Department of Statistics (D.L.G.), University of California Irvine, Irvine, the Infectious Disease Clinical Outcomes Research Unit, Division of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance (J.A.M., S.J.E., R.M.-G., M.A.B., L.G.M.), the Department of Pathology and Laboratory Medicine, University of California Irvine School of Medicine, Orange (K.E., E.P.), Ventura County Medical Center, Ventura (G.S.), the Division of Infectious Disease, Hoag Hospital, Newport Beach (P.R.), the Division of Infectious Disease, St. Mary Medical Center (C. Choi), and MemorialCare Health System (J.D.L.), Long Beach, and the Division of Infectious Disease, Mission Hospital, Mission Viejo (C.C.B.) - all in California · the Institute of Healthcare Improvement, Cambridge (D.G.), and the Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care, Boston (R.P.) - both in Massachusetts · the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta (J.A.J.) · Texas A&M Health Science Center, Houston (E.S.) · and Cook County Health and Hospitals System (R.A.W.) and the Division of Infectious Diseases, Rush University Medical Center (R.A.W., M.K.H.), Chicago. · Pubmed 30763195
  • University of California Irvine School of Medicine, Irvine, CA · Harbor-UCLA Medical Center, Torrance, CA. · Pubmed 31141648
2018
  • Infectious Disease Clinical Outcomes Research Unit (ID-CORE), Division of Infectious Disease, Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance, California. Electronic address: · Pharmerit International, Bethesda, Maryland. · Theravance Biopharma US, Inc, South San Francisco, California. · Albany College of Pharmacy and Health Sciences, Albany, Maryland. · Pubmed 29454592
2016
  • 1Infectious Disease Clinical OutcomesResearch Unit (ID-CORE),Division of Infectious Disease,Los Angeles Biomedical Research Institute,Harbor-UCLA Medical Center,Torrance,California. · 3Division of Infectious Diseases and Health Policy Research Institute,University of California,Irvine School of Medicine,Irvine,California. · 4Department of Biostatistics and Epidemiology,University of Massachusetts Amherst School of Public Health and Health Sciences,Amherst, Massachusetts. · 5Department of Pathology and Laboratory Medicine,University of California,Irvine School of Medicine,Irvine,California. · Pubmed 27671022
  • Department of Medical Affairs, Merck & Co Inc, Kenilworth, New Jersey. Electronic address: · Department of Medical Affairs, Merck & Co Inc, Kenilworth, New Jersey. · Department of Clinical Pharmacy and Pharmaceutical Economics & Policy, University of Southern California, Los Angeles, California. · Department of Pharmacy: Clinical and Administrative Sciences, University of Oklahoma College of Pharmacy, Oklahoma City, Oklahoma. · Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, Ohio. · Department of Pharmacy, St. Barnabas Health Care System, Livingston, New Jersey. · Department of Clinical Pharmacy, University Medical Center of Southern Nevada, Las Vegas, Nevada. · Division of Infectious Diseases, Yale-New Haven Hospital-SRC, New Haven, Connecticut. · Torrance Memorial Medical Center Division of Infectious Diseases & Infectious Disease Clinical Outcomes Research at LA Biomedical Research Institute, Torrance, California. · Department of Pharmacy Practice and Administration, Jersey Shore University Medical Center and Rutgers University, Neptune, New Jersey. · Department of Pharmacy, Glendale Adventist Medical Center, Glendale, California. · Albany College of Pharmacy, Albany, New York. · Division of Infectious Diseases, Henry Ford Hospital and Wayne State University, Detroit, Michigan. · Pubmed 26585355
2015
  • 1Infectious Disease Clinical Outcomes Research Unit,Division of Infectious Disease,Los Angeles Biomedical Research Institute,Harbor-UCLA Medical Center,Torrance,California. · 3Public Health Computational and Operations Research Group (PHICOR),Johns Hopkins Bloomberg School of Public Health,Baltimore,Maryland. · 5Division of Infectious Diseases and Health Policy Research Institute,University of California,Irvine School of Medicine,Irvine,California. · Pubmed 25627755
  • 1Infectious Disease Clinical Outcomes Research Unit,Division of Infectious Disease,Los Angeles Biomedical Research Institute,Harbor-UCLA Medical Center,Torrance,California. · 3Public Health Computational and Operations Research Group,Johns Hopkins Bloomberg School of Public Health,Baltimore,Maryland. · 4Division of Infectious Diseases and Health Policy Research Institute,University of California,Irvine School of Medicine,Irvine,California. · Pubmed 26081999
  • Department of Medical Affairs, Cubist Pharmaceuticals, Lexington, Massachusetts. · Infectious Disease Clinical Outcomes Unit, Los Angeles Biomedical Research Institute, David Geffen School of Medicine, University of California Torrance Memorial Medical Center, California. · Division of Pediatric Pharmacology and Drug Discovery, University of California, San Diego School of Medicine, La Jolla. · Pubmed 25371486
2014
  • Department of Medical Affairs, Cubist Pharmaceuticals, Lexington, Massachusetts. · Infectious Disease Clinical Outcomes Unit (ID-CORE), Los Angeles Biomedical Research Institute, David Geffen School of Medicine, University of California Department of Medicine, Torrance Memorial Medical Center. · Division of Pediatric Pharmacology and Drug Discovery, University of California San Diego School of Medicine, La Jolla. · Pubmed 25048852
2013
  • Infectious Disease Clinical Outcomes Research Unit, Division of Infectious Disease, Los Angeles Biomedical Research Institute at Harbor-University of California-Los Angeles Medical Center, Torrance, California. · Pubmed 24018925
  • Infectious Disease Clinical Outcomes Research Unit, Division of Infectious Disease, Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance, CA, USA. · Pubmed 23295562
2014
  • Division of Infectious Disease, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California. · Pubmed 24799655
2013
  • Division of Infectious Diseases, Harbor-UCLA Medical Center, and Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA 90509, USA · Pubmed 23217979
2011
  • Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA 90502, USA. · Pubmed 21098242
  • Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA. · Pubmed 21777408
  • LA Biomedical Research Institute at Harbor-UCLA, 1124 West Carson Street, Bldg. RB2, Room 230, Torrance, CA 90502, USA. · Pubmed 21709105
  • Infectious Diseases Clinical Outcomes Research Unit (ID-CORE), Division of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Los Angeles, California, USA. · Pubmed 21460485
Probable:    Hoag Memorial Hospital Presbyterian      
2019
  • From the Division of Infectious Diseases (S.S. Huang, R.S., S.P., D.K., S.R., T.T., C. Cao, S.S. Hong, J.L., E.C., J.C., J.H.), the Health Policy Research Institute (S.S. Huang), and the Department of Medicine (A.A.), University of California Irvine School of Medicine, and the Institute for Clinical and Translational Science (A.G.) and the Department of Statistics (D.L.G.), University of California Irvine, Irvine, the Infectious Disease Clinical Outcomes Research Unit, Division of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance (J.A.M., S.J.E., R.M.-G., M.A.B., L.G.M.), the Department of Pathology and Laboratory Medicine, University of California Irvine School of Medicine, Orange (K.E., E.P.), Ventura County Medical Center, Ventura (G.S.), the Division of Infectious Disease, Hoag Hospital, Newport Beach (P.R.), the Division of Infectious Disease, St. Mary Medical Center (C. Choi), and MemorialCare Health System (J.D.L.), Long Beach, and the Division of Infectious Disease, Mission Hospital, Mission Viejo (C.C.B.) - all in California · the Institute of Healthcare Improvement, Cambridge (D.G.), and the Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care, Boston (R.P.) - both in Massachusetts · the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta (J.A.J.) · Texas A&M Health Science Center, Houston (E.S.) · and Cook County Health and Hospitals System (R.A.W.) and the Division of Infectious Diseases, Rush University Medical Center (R.A.W., M.K.H.), Chicago. · Pubmed 30763195
Probable:    University of California Irvine   Contact    
2019
  • From the Division of Infectious Diseases (S.S. Huang, R.S., S.P., D.K., S.R., T.T., C. Cao, S.S. Hong, J.L., E.C., J.C., J.H.), the Health Policy Research Institute (S.S. Huang), and the Department of Medicine (A.A.), University of California Irvine School of Medicine, and the Institute for Clinical and Translational Science (A.G.) and the Department of Statistics (D.L.G.), University of California Irvine, Irvine, the Infectious Disease Clinical Outcomes Research Unit, Division of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance (J.A.M., S.J.E., R.M.-G., M.A.B., L.G.M.), the Department of Pathology and Laboratory Medicine, University of California Irvine School of Medicine, Orange (K.E., E.P.), Ventura County Medical Center, Ventura (G.S.), the Division of Infectious Disease, Hoag Hospital, Newport Beach (P.R.), the Division of Infectious Disease, St. Mary Medical Center (C. Choi), and MemorialCare Health System (J.D.L.), Long Beach, and the Division of Infectious Disease, Mission Hospital, Mission Viejo (C.C.B.) - all in California · the Institute of Healthcare Improvement, Cambridge (D.G.), and the Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care, Boston (R.P.) - both in Massachusetts · the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta (J.A.J.) · Texas A&M Health Science Center, Houston (E.S.) · and Cook County Health and Hospitals System (R.A.W.) and the Division of Infectious Diseases, Rush University Medical Center (R.A.W., M.K.H.), Chicago. · Pubmed 30763195
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 19 total) written by James A. McKinnell about Methicillin-Resistant Staphylococcus aureus:

  • Decolonization to Reduce Postdischarge Infection Risk among MRSA Carriers. 2019
  • Postdischarge Infection Risk among MRSA Carriers. Reply. 2019
  • Effective Antimicrobial Stewardship Strategies for Cost-effective Utilization of Telavancin for the Treatment of Patients With Hospital-acquired Bacterial Pneumonia Caused by Staphylococcus aureus. 2018
  • Discontinuation of contact precautions with the introduction of universal daily chlorhexidine bathing. 2017
  • Prevalence of and Factors Associated With Multidrug Resistant Organism (MDRO) Colonization in 3 Nursing Homes. 2016
  • Beyond the Intensive Care Unit (ICU): Countywide Impact of Universal ICU Staphylococcus aureus Decolonization. 2016
  • Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation. 2016
  • Cost-benefit analysis from the hospital perspective of universal active screening followed by contact precautions for methicillin-resistant Staphylococcus aureus carriers. 2015
  • Reply to O'Riordan et al. 2015
  • Reply to Eschenauer et al. 2015
Show List of Full Article Records
Google Searches

Learn more about James A. McKinnell using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
UCLA
Hoag Memorial Hospital Presbyterian
University of California Irvine
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
UCLA
2019
  • From the Division of Infectious Diseases (S.S. Huang, R.S., S.P., D.K., S.R., T.T., C. Cao, S.S. Hong, J.L., E.C., J.C., J.H.), the Health Policy Research Institute (S.S. Huang), and the Department of Medicine (A.A.), University of California Irvine School of Medicine, and the Institute for Clinical and Translational Science (A.G.) and the Department of Statistics (D.L.G.), University of California Irvine, Irvine, the Infectious Disease Clinical Outcomes Research Unit, Division of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance (J.A.M., S.J.E., R.M.-G., M.A.B., L.G.M.), the Department of Pathology and Laboratory Medicine, University of California Irvine School of Medicine, Orange (K.E., E.P.), Ventura County Medical Center, Ventura (G.S.), the Division of Infectious Disease, Hoag Hospital, Newport Beach (P.R.), the Division of Infectious Disease, St. Mary Medical Center (C. Choi), and MemorialCare Health System (J.D.L.), Long Beach, and the Division of Infectious Disease, Mission Hospital, Mission Viejo (C.C.B.) - all in California · the Institute of Healthcare Improvement, Cambridge (D.G.), and the Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care, Boston (R.P.) - both in Massachusetts · the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta (J.A.J.) · Texas A&M Health Science Center, Houston (E.S.) · and Cook County Health and Hospitals System (R.A.W.) and the Division of Infectious Diseases, Rush University Medical Center (R.A.W., M.K.H.), Chicago. · Pubmed 30763195
  • University of California Irvine School of Medicine, Irvine, CA · Harbor-UCLA Medical Center, Torrance, CA. · Pubmed 31141648
2018
  • Infectious Disease Clinical Outcomes Research Unit (ID-CORE), Division of Infectious Disease, Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance, California. Electronic address: · Pharmerit International, Bethesda, Maryland. · Theravance Biopharma US, Inc, South San Francisco, California. · Albany College of Pharmacy and Health Sciences, Albany, Maryland. · Pubmed 29454592
2016
  • 1Infectious Disease Clinical OutcomesResearch Unit (ID-CORE),Division of Infectious Disease,Los Angeles Biomedical Research Institute,Harbor-UCLA Medical Center,Torrance,California. · 3Division of Infectious Diseases and Health Policy Research Institute,University of California,Irvine School of Medicine,Irvine,California. · 4Department of Biostatistics and Epidemiology,University of Massachusetts Amherst School of Public Health and Health Sciences,Amherst, Massachusetts. · 5Department of Pathology and Laboratory Medicine,University of California,Irvine School of Medicine,Irvine,California. · Pubmed 27671022
  • Department of Medical Affairs, Merck & Co Inc, Kenilworth, New Jersey. Electronic address: · Department of Medical Affairs, Merck & Co Inc, Kenilworth, New Jersey. · Department of Clinical Pharmacy and Pharmaceutical Economics & Policy, University of Southern California, Los Angeles, California. · Department of Pharmacy: Clinical and Administrative Sciences, University of Oklahoma College of Pharmacy, Oklahoma City, Oklahoma. · Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, Ohio. · Department of Pharmacy, St. Barnabas Health Care System, Livingston, New Jersey. · Department of Clinical Pharmacy, University Medical Center of Southern Nevada, Las Vegas, Nevada. · Division of Infectious Diseases, Yale-New Haven Hospital-SRC, New Haven, Connecticut. · Torrance Memorial Medical Center Division of Infectious Diseases & Infectious Disease Clinical Outcomes Research at LA Biomedical Research Institute, Torrance, California. · Department of Pharmacy Practice and Administration, Jersey Shore University Medical Center and Rutgers University, Neptune, New Jersey. · Department of Pharmacy, Glendale Adventist Medical Center, Glendale, California. · Albany College of Pharmacy, Albany, New York. · Division of Infectious Diseases, Henry Ford Hospital and Wayne State University, Detroit, Michigan. · Pubmed 26585355
2015
  • 1Infectious Disease Clinical Outcomes Research Unit,Division of Infectious Disease,Los Angeles Biomedical Research Institute,Harbor-UCLA Medical Center,Torrance,California. · 3Public Health Computational and Operations Research Group (PHICOR),Johns Hopkins Bloomberg School of Public Health,Baltimore,Maryland. · 5Division of Infectious Diseases and Health Policy Research Institute,University of California,Irvine School of Medicine,Irvine,California. · Pubmed 25627755
  • 1Infectious Disease Clinical Outcomes Research Unit,Division of Infectious Disease,Los Angeles Biomedical Research Institute,Harbor-UCLA Medical Center,Torrance,California. · 3Public Health Computational and Operations Research Group,Johns Hopkins Bloomberg School of Public Health,Baltimore,Maryland. · 4Division of Infectious Diseases and Health Policy Research Institute,University of California,Irvine School of Medicine,Irvine,California. · Pubmed 26081999
  • Department of Medical Affairs, Cubist Pharmaceuticals, Lexington, Massachusetts. · Infectious Disease Clinical Outcomes Unit, Los Angeles Biomedical Research Institute, David Geffen School of Medicine, University of California Torrance Memorial Medical Center, California. · Division of Pediatric Pharmacology and Drug Discovery, University of California, San Diego School of Medicine, La Jolla. · Pubmed 25371486
2014
  • Department of Medical Affairs, Cubist Pharmaceuticals, Lexington, Massachusetts. · Infectious Disease Clinical Outcomes Unit (ID-CORE), Los Angeles Biomedical Research Institute, David Geffen School of Medicine, University of California Department of Medicine, Torrance Memorial Medical Center. · Division of Pediatric Pharmacology and Drug Discovery, University of California San Diego School of Medicine, La Jolla. · Pubmed 25048852
2013
  • Infectious Disease Clinical Outcomes Research Unit, Division of Infectious Disease, Los Angeles Biomedical Research Institute at Harbor-University of California-Los Angeles Medical Center, Torrance, California. · Pubmed 24018925
  • Infectious Disease Clinical Outcomes Research Unit, Division of Infectious Disease, Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance, CA, USA. · Pubmed 23295562
2014
  • Division of Infectious Disease, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California. · Pubmed 24799655
2013
  • Division of Infectious Diseases, Harbor-UCLA Medical Center, and Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA 90509, USA · Pubmed 23217979
2011
  • Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA 90502, USA. · Pubmed 21098242
  • Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA. · Pubmed 21777408
  • LA Biomedical Research Institute at Harbor-UCLA, 1124 West Carson Street, Bldg. RB2, Room 230, Torrance, CA 90502, USA. · Pubmed 21709105
  • Infectious Diseases Clinical Outcomes Research Unit (ID-CORE), Division of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Los Angeles, California, USA. · Pubmed 21460485
Hoag Memorial Hospital Presbyterian
2019
  • From the Division of Infectious Diseases (S.S. Huang, R.S., S.P., D.K., S.R., T.T., C. Cao, S.S. Hong, J.L., E.C., J.C., J.H.), the Health Policy Research Institute (S.S. Huang), and the Department of Medicine (A.A.), University of California Irvine School of Medicine, and the Institute for Clinical and Translational Science (A.G.) and the Department of Statistics (D.L.G.), University of California Irvine, Irvine, the Infectious Disease Clinical Outcomes Research Unit, Division of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance (J.A.M., S.J.E., R.M.-G., M.A.B., L.G.M.), the Department of Pathology and Laboratory Medicine, University of California Irvine School of Medicine, Orange (K.E., E.P.), Ventura County Medical Center, Ventura (G.S.), the Division of Infectious Disease, Hoag Hospital, Newport Beach (P.R.), the Division of Infectious Disease, St. Mary Medical Center (C. Choi), and MemorialCare Health System (J.D.L.), Long Beach, and the Division of Infectious Disease, Mission Hospital, Mission Viejo (C.C.B.) - all in California · the Institute of Healthcare Improvement, Cambridge (D.G.), and the Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care, Boston (R.P.) - both in Massachusetts · the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta (J.A.J.) · Texas A&M Health Science Center, Houston (E.S.) · and Cook County Health and Hospitals System (R.A.W.) and the Division of Infectious Diseases, Rush University Medical Center (R.A.W., M.K.H.), Chicago. · Pubmed 30763195
University of California Irvine
2019
  • From the Division of Infectious Diseases (S.S. Huang, R.S., S.P., D.K., S.R., T.T., C. Cao, S.S. Hong, J.L., E.C., J.C., J.H.), the Health Policy Research Institute (S.S. Huang), and the Department of Medicine (A.A.), University of California Irvine School of Medicine, and the Institute for Clinical and Translational Science (A.G.) and the Department of Statistics (D.L.G.), University of California Irvine, Irvine, the Infectious Disease Clinical Outcomes Research Unit, Division of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance (J.A.M., S.J.E., R.M.-G., M.A.B., L.G.M.), the Department of Pathology and Laboratory Medicine, University of California Irvine School of Medicine, Orange (K.E., E.P.), Ventura County Medical Center, Ventura (G.S.), the Division of Infectious Disease, Hoag Hospital, Newport Beach (P.R.), the Division of Infectious Disease, St. Mary Medical Center (C. Choi), and MemorialCare Health System (J.D.L.), Long Beach, and the Division of Infectious Disease, Mission Hospital, Mission Viejo (C.C.B.) - all in California · the Institute of Healthcare Improvement, Cambridge (D.G.), and the Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care, Boston (R.P.) - both in Massachusetts · the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta (J.A.J.) · Texas A&M Health Science Center, Houston (E.S.) · and Cook County Health and Hospitals System (R.A.W.) and the Division of Infectious Diseases, Rush University Medical Center (R.A.W., M.K.H.), Chicago. · Pubmed 30763195
Miscellaneous institutions in Torrance
2017
  • Torrance Memorial Medical Center,Torrance,California,USA. · Division of Infectious Disease,Los Angeles Biomedical Research Institute,Torrance,California,USA. · Division of Infectious Diseases and Health Policy Research Institute,University of California,Irvine School of Medicine,Irvine,California,USA. · Pubmed 28597809
Yearly article counts 21133230400
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.